World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
67
Citations
21239
World Ranking
2648
National Ranking
1265

Cassian Yee publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Cassian Yee sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 234 publications — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Cassian Yee D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Cassian Yee sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 67 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Cassian Yee is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research activity primarily spans the fields of Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. Within these broad areas, they have contributed extensively to subfields such as Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine, and Genetics.

The scientist's work focuses on several interconnected topics, including Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Immunotherapy and Immune Responses, Immune Cell Function and Interaction, vaccines and immunoinformatics approaches, Immune cells in cancer, and SARS-CoV-2 and COVID-19 Research.

Cassian Yee has published research in various journals, with frequent contributions to:

  • Cancer Research
  • Regular and Young Investigator Award Abstracts
  • Journal for ImmunoTherapy of Cancer
  • Journal of Clinical Oncology
  • Nature Communications

Their recent significant papers include:

  • "Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance," 2023, Nature Medicine
  • "Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity," 2022, Cancer Cell
  • "The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1," 2021, Cancer Cell
  • "Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma," 2020, Cancer Discovery
  • "Combination of PD-1 Inhibitor and OX40 Agonist Induces Tumor Rejection and Immune Memory in Mouse Models of Pancreatic Cancer," 2020, Gastroenterology

Frequent co-authors collaborating with Cassian Yee include:

  • Shailbala Singh
  • Adi Diab
  • Michael A. Davies
  • Sapna P. Patel
  • Yulun Chiu

Best Publications

  • Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

    Veronika Groh;Jennifer Wu;Cassian Yee;Thomas Spies

  • Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells

    C. Yee;C. Yee;J. A. Thompson;J. A. Thompson;D. Byrd;D. Byrd;S. R. Riddell;S. R. Riddell

  • Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients.

    Peter P. Lee;Cassian Yee;Peter A. Savage;Lawrence Fong

  • Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1.

    Naomi N. Hunder;Herschel Wallen;Jianhong Cao;Deborah W. Hendricks

  • Generation and testing of clinical-grade exosomes for pancreatic cancer

    Mayela Mendt;Sushrut Kamerkar;Hikaru Sugimoto;Kathleen M. McAndrews

  • Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo.

    Cassian Yee;John A. Thompson;Patrick Roche;David R. Byrd

  • Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers.

    Cassian Yee;Peter A. Savage;Peter P. Lee;Mark M. Davis

  • Autoreactive T Cells in Healthy Individuals

    Nancy A. Danke;David M. Koelle;Cassian Yee;Sucheta Beheray

  • Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance

    Unknown

  • Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity.

    Unknown

  • Transferred WT1-Reactive CD8+ T Cells Can Mediate Antileukemic Activity and Persist in Post-Transplant Patients

    Aude G. Chapuis;Gunnar B. Ragnarsson;Hieu N. Nguyen;Colette N. Chaney

  • CD3- and CD28-dependent induction of PDE7 required for T cell activation

    Linsong Li;Cassian Yee;Joseph A. Beavo

  • IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response.

    Yongqing Li;Marie Bleakley;Cassian Yee

  • Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer.

    Jorge Blando;Anu Sharma;Maria Gisela Higa;Hao Zhao

  • Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience

    Omar Mamlouk;Umut Selamet;Shana Machado;Maen Abdelrahim

  • The effect of radiation on the immune response to cancers.

    Bonggoo Park;Cassian Yee;Kyung Mi Lee

  • Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature.

    Houssein Safa;Daniel H Johnson;Van Anh Trinh;Theresa E Rodgers

  • The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1

    Hongzhong Li;Yi Xiao;Qin Li;Jun Yao

  • Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA

    K. G. Paulson;K. G. Paulson;K. G. Paulson;V. Voillet;M. S. McAfee;D. S. Hunter

  • Ultra-sensitive detection of rare T cell clones

    Harlan Robins;Cindy Desmarais;Jessica Matthis;Robert Livingston

  • Future perspectives in melanoma research

    Paolo A. Ascierto;Sanjiv Agarwala;Gerardo Botti;Alessandra Cesano

  • Adoptive immunotherapy: engineering T cell responses as biologic weapons for tumor mass destruction.

    William Y Ho;Joseph N Blattman;Michelle L Dossett;Cassian Yee

  • Dissolution Chemistry and Biocompatibility of Single-Crystalline Silicon Nanomembranes and Associated Materials for Transient Electronics

    Suk Won Hwang;Gayoung Park;Chris Edwards;Elise A. Corbin

Frequent Co-Authors

Patrick Hwu
Patrick Hwu The University of Texas MD Anderson Cancer Center
Philip D. Greenberg
Philip D. Greenberg Fred Hutchinson Cancer Research Center
Michael A. Davies
Michael A. Davies The University of Texas MD Anderson Cancer Center
Adi Diab
Adi Diab The University of Texas MD Anderson Cancer Center
Stanley R. Riddell
Stanley R. Riddell University of Washington
Chantale Bernatchez
Chantale Bernatchez The University of Texas MD Anderson Cancer Center
Jennifer A. Wargo
Jennifer A. Wargo The University of Texas MD Anderson Cancer Center
David M. Koelle
David M. Koelle University of Washington
Cara Haymaker
Cara Haymaker The University of Texas MD Anderson Cancer Center
Alexander J. Lazar
Alexander J. Lazar The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring complementary healthcare fields can open diverse career opportunities. Many students consider bridging into clinical roles through online nursing programs for non nurses, which provide foundational nursing knowledge without prior nursing experience. These programs serve as an accessible entry point to healthcare careers, combining flexibility with comprehensive coursework.

Accelerated pathways are also popular for individuals seeking to advance quickly. The easiest accelerated nursing programs offer streamlined curriculums for students who already hold a degree in another discipline, allowing them to transition efficiently into nursing. This approach is ideal for professionals wanting to integrate immunology insights with practical nursing skills.

For those aiming to start with practical nursing credentials, options like lpn programs easy to get into can be an excellent stepping stone. These programs typically focus on hands-on patient care and can lead to immediate employment in healthcare settings, helping students build relevant clinical experience in immunology-related fields.

Additionally, advancing to specialized roles is possible through nurse practitioner degrees. Understanding what is the easiest np program can guide prospective students toward manageable graduate-level options that enhance clinical decision-making and patient management, often integrating immunology concepts in advanced practice.

Best Scientists Citing Cassian Yee

Trending Scientists

Recently Published Articles